Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Preveceutical Medical Inc PRVCF


Primary Symbol: C.PREV

PreveCeutical Medical Inc. is a Canada-based health sciences company. The Company’s principal business activity is the development of options for preventive and curative therapies utilizing organic and nature identical products. The Company’s pipeline includes Cannabinoid Sol-Gel, Non-Addictive Analgesic, BSV Peptide Program and Dual Gene Therapy. Its Cannabinoid Sol-Gel is a cannabinoid-based... see more

Recent & Breaking News (CSE:PREV)

PreveCeutical Provides Corporate Update

Newsfile May 31, 2021

PreveCeutical Appoints Founding Director of RAS Life Science Solutions Aditya Bahl as Advisor

Newsfile March 15, 2021

PreveCeutical Announces Debt Settlement and Conversion of Debt

Newsfile March 12, 2021

Accomplished Biophysicist Linnéa Olofsson, Ph.D. joins PreveCeutical

Newsfile February 23, 2021

PreveCeutical Announces Completion of Pain Management Peptides Program

Newsfile February 2, 2021

PreveCeutical files Provisional Patent Application for its BSV Peptide

Newsfile January 5, 2021

Successful Completion of the COVID-19 Sol-Gel Formulation Development

Newsfile November 25, 2020

PreveCeutical Files Provisional Patent Application for its COVID-19 Formulation

Newsfile November 23, 2020

PreveCeutical Provides Update on Its COVID-19 Cannabinoid Sol-Gel Program

Newsfile November 10, 2020

PreveCeutical Receives Extension of Six Months to Hold its Annual General Meeting from the Registrar of Companies, British Columbia

Newsfile October 29, 2020

PreveCeutical's Application for COVID-19 Therapy Funding Update

Newsfile October 9, 2020

IIROC Trade Resumption - PREV

Canada NewsWire October 1, 2020

Veteran Johnson & Johnson Executive Dr. Ajit Shetty Joins PreveCeutical

Newsfile October 1, 2020

IIROC Trading Halt - PREV

Canada NewsWire October 1, 2020

PreveCeutical Provides Lead Pain Management Peptides Update

Newsfile September 8, 2020

PreveCeutical Announces Lead Pain Management Peptides Identified for Preclinical Evaluation

Newsfile September 2, 2020

PreveCeutical Files an Application for a Provisional Patent for Sol-gel Cannabinoids

Newsfile August 31, 2020

PreveCeutical Receives AU$1,227,902 Research & Development Tax Incentive Cash Refund

Newsfile August 17, 2020

IIROC Trade Resumption - PREV

Canada NewsWire August 4, 2020

PreveCeutical Prepares for Clinical Trials for its Sol-Gel COVID-19 Program

Canada NewsWire August 4, 2020